Announcements Trials
Browse Landscape

Status

Unknown 4Recruiting 4Terminated 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 4

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 4Gynecologic 3Lymphoid 2Head & Neck 2Genitourinary 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1NET 1Endocrine 1CNS 1Breast 1

Conditions

Neoplasms 4

Interventions

pembrolizumab 25Specimen Handling 17Blood Specimen Collection 17Biopsy 16Magnetic Resonance Spectroscopy 15atezolizumab 11Surveys and Questionnaires 11Radiosurgery 9Bevacizumab 9Paclitaxel 8Fluorouracil 8Standard of Care 7Radiotherapy 7Nivolumab 7Irinotecan 7Gemcitabine 7Cisplatin 7Carboplatin 7olaparib 6durvalumab 6Palliative Care 6Oxaliplatin 6Leucovorin 6Cyclophosphamide 6Capecitabine 6alectinib 5abemaciclib 5Trastuzumab 5Interviews as Topic 5Exercise 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Data Collection × Tumor-Agnostic × Clear all
NCT05427136 2026-05-08

SWISS-Pearl

University Children's Hospital Basel

Recruiting
140 enrolled
Tumor-Agnostic

Neoplasms

NCT00684580 2026-04-29

Protocol For Collecting Data On Patients With Childhood Cancer

St. Jude Children's Research Hospital

Recruiting
30,000 enrolled
Tumor-Agnostic

Neoplasms

NCT04477681 2026-03-31

SACHA

Gustave Roussy, Cancer Campus, Grand Paris

Recruiting
1,150 enrolled
Tumor-Agnostic

Neoplasms

NCT06270602 2025-12-22

The ONCOCAMP Study

National Cancer Institute, Naples

Recruiting
15,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡